BARBARA WILHELM: Open Payments
NPI 1154385565 · FARMINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 45 payments from 12 companies in 2025. Trend: 2023 $1,345 · 2024 $1,220 · 2025 $849
Food & beverage: $849
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $218 |
| Novo Nordisk Inc | 9 | $164 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $92 |
| Otsuka America Pharmaceutical, Inc. | 4 | $71 |
| PFIZER INC. | 4 | $68 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| Amgen Inc. | 3 | $57 |
| Lilly USA, LLC | 2 | $35 |
| Abbott Laboratories | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
Products named: FARXIGA, Kerendia, REXULTI, Wegovy, TRELEGY ELLIPTA, OTEZLA, Ozempic, MOUNJARO.
Industry payments across PA — which companies pay providers there.
